Literature DB >> 18045168

The NMDA receptor/ion channel complex: a drug target for modulating synaptic plasticity and excitotoxicity.

Benedict C Albensi1.   

Abstract

A recent search on PubMed for the phrase NMDA receptor results in 2,190 hits on this topic for review articles and 20,100 hits for experimental papers. This is a direct reflection of the intensiveness, significance, and complexity associated with the research on this key receptor protein over the last several decades. In this review, we briefly describe the NMDA receptor structure, discuss the role of NMDA receptors in modulating synaptic plasticity and excitotoxicity, explore age-dependent changes in NMDA receptor functioning, and survey interesting NMDA receptor blockers. Given the huge existing literature on the subject, an exhaustive review has not been endeavored. Instead, an attempt was made to point out those studies that have been instrumental in the field or that are of special interest.

Mesh:

Substances:

Year:  2007        PMID: 18045168     DOI: 10.2174/138161207782341321

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  16 in total

1.  A new look at glutamate and ischemia: NMDA agonist improves long-term functional outcome in a rat model of stroke.

Authors:  Jasbeer Dhawan; Helene Benveniste; Zhongchi Luo; Marta Nawrocky; S David Smith; Anat Biegon
Journal:  Future Neurol       Date:  2011-11-01

2.  An in vitro protocol for recording from spinal motoneurons of adult rats.

Authors:  Jonathan S Carp; Ann M Tennissen; Donna L Mongeluzi; Christopher J Dudek; Xiang Yang Chen; Jonathan R Wolpaw
Journal:  J Neurophysiol       Date:  2008-05-07       Impact factor: 2.714

Review 3.  Roles for NF-κB and gene targets of NF-κB in synaptic plasticity, memory, and navigation.

Authors:  Wanda M Snow; Brenda M Stoesz; Debbie M Kelly; Benedict C Albensi
Journal:  Mol Neurobiol       Date:  2013-10-13       Impact factor: 5.590

4.  Solid-phase synthesis of a library of amphipatic hydantoins. Discovery of new hits for TRPV1 blockade.

Authors:  Guillermo Gerona-Navarro; Rosario González-Muñiz; Asia Fernández-Carvajal; José M González-Ros; Antonio Ferrer-Montiel; Cristina Carreño; Fernando Albericio; Miriam Royo
Journal:  ACS Comb Sci       Date:  2011-07-08       Impact factor: 3.784

5.  NR2B-containing NMDA receptors expression and their relationship to apoptosis in hippocampus of Alzheimer's disease-like rats.

Authors:  Zhi'an Liu; Chun'e Lv; Weiwei Zhao; Yuanjian Song; Dongsheng Pei; Tiejun Xu
Journal:  Neurochem Res       Date:  2012-02-23       Impact factor: 3.996

Review 6.  Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration.

Authors:  Juan A Orellana; Pablo J Sáez; Kenji F Shoji; Kurt A Schalper; Nicolás Palacios-Prado; Victoria Velarde; Christian Giaume; Michael V L Bennett; Juan C Sáez
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

Review 7.  Lithium's role in neural plasticity and its implications for mood disorders.

Authors:  J D Gray; B S McEwen
Journal:  Acta Psychiatr Scand       Date:  2013-04-26       Impact factor: 6.392

8.  Human immunodeficiency virus-1 Tat protein increases the number of inhibitory synapses between hippocampal neurons in culture.

Authors:  Nicholas J Hargus; Stanley A Thayer
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

9.  Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate.

Authors:  Pilar Sánchez-Blázquez; María Rodríguez-Muñoz; Ana Vicente-Sánchez; Javier Garzón
Journal:  Antioxid Redox Signal       Date:  2013-06-01       Impact factor: 8.401

10.  Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death.

Authors:  Hee Jung Kim; Kirill A Martemyanov; Stanley A Thayer
Journal:  J Neurosci       Date:  2008-11-26       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.